{
    "eid": "2-s2.0-85117503838",
    "title": "Progesterone Receptor Signaling in the Breast Tumor Microenvironment",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Cancer-associated fibroblasts (CAFs)",
        "Cytokines",
        "Cytokines",
        "Estrogen receptor",
        "Extracellular matrix",
        "Immune cells",
        "Paracrine",
        "Progesterone receptor",
        "Stem cells",
        "Stroma",
        "Tumor progression"
    ],
    "authors": [
        "Viroj Boonyaratanakornkit",
        "Eileen M. McGowan",
        "Diana C. M\u00e1rquez-Garb\u00e1n",
        "L. P. Burton",
        "Nalo Hamilton",
        "Prangwan Pateetin",
        "Richard J. Pietras"
    ],
    "citedby-count": 3,
    "ref-count": 187,
    "ref-list": [
        "Dose-response trial of megestrol acetate in advanced breast cancer: Cancer and leukemia group B phase III study 8741",
        "S2rpgrmc1: The cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling",
        "Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene",
        "The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis",
        "Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database",
        "Form and function: How estrogen and progesterone regulate the mammary epithelial hierarchy",
        "Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium",
        "Progesterone vs. Synthetic progestins and the risk of breast cancer: A systematic review and meta-analysis",
        "Control of mammary stem cell function by steroid hormone signalling",
        "Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism",
        "Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells",
        "Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases",
        "Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland",
        "Breast cancer and hormone-replacement therapy in the Million Women Study",
        "Hormone replacement therapy and high incidence of breast cancer between mammographic screens",
        "Use of HRT and the subsequent risk of cancer",
        "Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells",
        "Type-2 pericytes participate in normal and tumoral angiogenesis",
        "Tissue architecture: The ultimate regulator of breast epithelial function",
        "Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases",
        "The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle",
        "Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer",
        "Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer",
        "Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands",
        "Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor",
        "Progesterone signalling in breast cancer: A neglected hormone coming into the limelight",
        "Hormone action in the mammary gland",
        "Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling",
        "Progesterone receptor membrane component 1: An integrative review",
        "The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology",
        "Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003",
        "Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women",
        "Breast cancer after use of estrogen plus progestin and estrogen alone: Analyses of data from 2 women\u2019s health Initiative randomized clinical trials",
        "Menopausal hormone therapy influence on breast cancer outcomes in the women\u2019s health initiative",
        "Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis",
        "Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer",
        "Dissociation between steroid receptor expression and cell proliferation in the human breast",
        "A putative human breast stem cell population is enriched for steroid receptor-positive cells",
        "Wnt/\u03b2-catenin signaling and disease",
        "Risk factors for breast cancer according to estrogen and progesterone receptor status",
        "Type and timing of menopausal hormone therapy and breast cancer risk: Individual participant meta-analysis of the worldwide epidemiological evidence",
        "Reproductive functions of progesterone receptors",
        "Progesterone signaling in mammary gland development",
        "Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action",
        "Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells",
        "Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-and estrogen receptor-containing transcription complexes",
        "Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models",
        "Membrane progesterone receptor expression in mammalian tissues: A review of regulation and physiological implications",
        "Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)",
        "Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects",
        "Progesterone receptor rapid signaling mediates Ser345 phosphorylation and tethering to Sp1 transcription factors",
        "The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development",
        "Tumor neurobiology and the war of nerves in cancer",
        "From the ranks of mammary progesterone mediators, RANKL takes the spotlight",
        "The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse",
        "Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III",
        "Foxp3 programs the development and function of CD4+CD25+ regulatory T cells",
        "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort",
        "Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study",
        "Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton",
        "Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase",
        "Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer",
        "RANKL inhibition: A promising novel strategy for breast cancer treatment",
        "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis",
        "Progesterone receptor attenuates STAT1-mediated IFN signaling in breast cancer",
        "Physiological action of progesterone in target tissues",
        "DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast",
        "Estrogen and progesterone receptors in murine models of systemic lupus erythematosus",
        "Progesterone receptor signaling mechanisms",
        "Tissue architecture and breast cancer: The role of extracellular matrix and steroid hormones",
        "The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones",
        "The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland",
        "Effect of oestradiol on progesterone receptors in normal mammary glands and its relationship with lactation",
        "Host microenvironment in breast cancer development: Epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland",
        "National use of postmenopausal hormone therapy: Annual trends and response to recent evidence",
        "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast",
        "Progesterone stimulates progenitor cells in normal human breast and breast cancer cells",
        "Estrogen and progesterone signalling in the normal breast and its implications for cancer development",
        "Human breast development",
        "Progesterone and autoimmune disease",
        "The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses",
        "RANKL/RANK/OPG system beyond bone remodeling: Involvement in breast cancer and clinical perspectives",
        "Progesterone involvement in breast development and tumorigenesis \u2013 as revealed by progesterone receptor \u201cknockout\u201d and \u201cknockin\u201d mouse models",
        "Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/proges-terone receptor-positive breast cancers",
        "Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy",
        "Nerve\u2013 cancer cell cross-talk: A novel promoter of tumor progression",
        "Regulation of cancer cell migration and bone metastasis by RANKL",
        "Progesterone induces adult mammary stem cell expansion",
        "Progesterone exposure and breast cancer risk: Understanding the biological roots",
        "Fibroblasts in cancer",
        "Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells",
        "Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease",
        "Minireview: The OPG/RANKL/RANK system",
        "Wnt/\u03b2--catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome",
        "Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer",
        "Distinct nuclear receptor expression in stroma adjacent to breast tumors",
        "Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression",
        "Role of progesterone in peripheral nerve repair",
        "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis",
        "Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development",
        "Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors",
        "Mammary development, carcinomas and progesterone: Role of Wnt signalling",
        "Challenges to defining a role for progesterone in breast cancer",
        "Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells",
        "Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age",
        "Inflammatory breast cancer biology: The tumour microenvironment is key",
        "Mammary gland development",
        "The prognostic significance of B lymphocytes in invasive carcinoma of the breast",
        "The nuclear receptor superfamily: The second decade",
        "Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice",
        "Current status of high dose progestin treatment in advanced breast cancer",
        "Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells",
        "Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels",
        "Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts",
        "Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor",
        "FOXP3 expression and overall survival in breast cancer",
        "Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer",
        "Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor",
        "Wnts as ligands: Processing, secretion and reception",
        "Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: Possible regulator of in situ steroidogenesis",
        "Progesterone receptor modulates ER\u03b1 action in breast cancer",
        "The role of chemoattraction in cancer metastases",
        "Abstract 465: Progestin-driven regulatory T cells directly promote an aggressive and metastatic phenotype in triple-negative breast cancer",
        "Hormonal contraception and HIV acquisition: Reanalysis using marginal structural modeling",
        "Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle",
        "Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma",
        "Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis",
        "Progesterone receptor isoforms in normal and malignant breast",
        "Sex hormones in acquired immunity and autoimmune disease",
        "Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue",
        "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression",
        "Reproductive tissue selective actions of progesterone receptors",
        "Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform",
        "Non-reproductive effects of sex steroids: Their immunoregulatory role",
        "Immunohistochemistry of estrogen and progesterone receptors reconsidered: Experience with 5,993 breast cancers",
        "Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets",
        "A new nomenclature for int-1 and related genes: The Wnt gene family",
        "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis",
        "RANK and EGFR in invasive breast carcinoma",
        "Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A",
        "Ablation of sensory nerves favours melanoma progression",
        "Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer",
        "Microenvironmental regulation of tumor progression and metastasis",
        "Paracrine signaling by progesterone",
        "RANKL and RANK: From mammalian physiology to cancer treatment",
        "Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis",
        "Side-branching in the mammary gland: The progesterone\u2013Wnt connection",
        "The role of the estrogen pathway in the tumor microenvironment",
        "Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland",
        "Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance",
        "Progestin and breast cancer risk: A systematic review",
        "Progesterone and breast cancer: An NCI workshop report",
        "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer",
        "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis",
        "B cell regulation of the anti-tumor response and role in carcinogenesis",
        "Generation of a functional mammary gland from a single stem cell",
        "Expression of nerve growth factor and its receptors NTRK1 and TNFRSF1B is regulated by estrogen and progesterone in the uteri of golden hamsters",
        "Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling",
        "Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland",
        "Purification and unique properties of mammary epithelial stem cells",
        "The role of progesterone in Feto-maternal immunological cross talk",
        "Induction of regulatory T cells by physiological level estrogen",
        "Hormonal modulation of the immune system \u2013 a spotlight on the role of progestogens",
        "Progesterone/RANKL is a major regulatory axis in the human breast",
        "Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor \u03b1 subtypes and their evolutionary origins",
        "Phosphorylated progesterone receptor isoforms mediate opposing stem cell and proliferative breast cancer cell fates",
        "RANKL-RANK signaling in osteoclastogenesis and bone disease",
        "Progesterone action in normal mouse mammary gland",
        "The sex hormone system in carriers of BRCA1/2 mutations: A case-control study",
        "Progesterone metabolites in breast cancer",
        "Progesterone metabolites regulate induction, growth, and suppression of estrogen-and progesterone receptor-negative human breast cell tumors",
        "A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer",
        "The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland",
        "ProTECT: A randomized clinical trial of progesterone for acute traumatic brain injury",
        "Very early administration of progesterone for acute traumatic brain injury",
        "Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (MTOR) in endometrial cancer cells",
        "Cancer associated fibroblasts (CAFs) in tumor microenvironment",
        "Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex",
        "Declining incidence of breast cancer after decreased use of hormone-replacement therapy: Magnitude and time lags in different countries",
        "Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase",
        "Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy",
        "A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors",
        "American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer",
        "DNA binding triggers tetramerization of the glucocorticoid receptor in live cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60073525",
            "affilname": "Guangdong Pharmaceutical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073525",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60023932",
            "affilname": "University of Technology Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023932",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60005247",
            "affilname": "David Geffen School of Medicine at UCLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}